Leo Yasinski

Leo Yasinski's work experience starts with their role as an Executive Director of Strategy and Market Access at Innoviva Specialty Therapeutics, Inc. starting in 2023. Prior to this, they held the position of Senior Director of Strategy and Market Access at La Jolla Pharmaceutical Company from 2019. Leo was also an Executive Director of Strategy and Market Access at Tetraphase Pharmaceuticals during the same year. Before joining Tetraphase, they worked at Merck as an Associate Director of Managed Markets and Policy in the Payer and Hospital Federal division from 2015 to 2019. Their role at Merck also included being an Associate Director of Managed Markets and Policy in the Sub Acute Division from 2015 to 2017. Leo's earlier experience includes roles at Cubist Pharmaceuticals where they served as a Strategic Account Manager and a Regional Business Director. Leo also worked as a Consultant at ZARS Pharma and held various positions at Wyeth Pharmaceuticals. Prior to their career in the pharmaceutical industry, Leo worked as an Athletic Director and a Mathematics Teacher at different school districts.

Leo Yasinski completed their education from 1992 to 1999 at Boise State University, where they obtained a Masters in Education. During this period, their field of study was Mathematics, with a concentration in Curriculum and Instruction.